The Relation between eNOS −786 C/T, 4 a/b, MMP-13 rs640198 G/T, Eotaxin 426 C/T, −384 A/G, and 67 G/A Polymorphisms and Long-Term Outcome in Patients with Coronary Artery Disease

Table 1

Basic characteristics of patients. Data are shown as mean ± SD.

Total/men []	532/407
Age [years]	65.4 ± 9.6
BMI [kg/m^2]	28.7 ± 4.0
One-vessel/two-vessel/three-vessel disease []	142/164/226
Smokers (%)	52%
Hypertension (%)	80%
Diabetes (%)	34%
EF (%)	55% (45%–60%)
Renal insufficiency: serum creatinine 105–200 μmol/L (men) or 85–200 μmol/L (women) (%)	23%
Creatinine [μmol/L]	101 (92–113)
Uric acid [μmol/L]	376 ± 106
Plasma glucose [mmol/L]	5.4 (4.9–6.5)
Cholesterol [mmol/L]	4.36 (4.72–5.10)
LDL [mmol/L]	2.38 (1.94–3.01)
HDL [mmol/L]	1.08 (0.93–1.27)
Triacylglycerols [mmol/L]	1.55 (1.20–2.09)
CRP [mg/L]	4.0 (1.8–7.4)
Medication (%):
ASA	92%
Other antiplatelet	54%
Warfarin	3%
β-blocker	94%
ACE-inhibitor	65%
AT1-blocker	20%
Statin	97%
Other antilipids	3%